total assets amounted of 57,941.6 million baht, decreased by 2,347.1 million baht from: Unit: million baht As at December 31, 2017 As at December 31, 2016 Variance Current assets Cash & cash equivalents
to 61,310.4 million baht, increasing by 3,368.8 million baht from: Unit: million baht As at June 30, 2018 As at December 31, 2017 Variance Current assets Cash and cash equivalents 8,153.4 9,995.9
) อัตราส่วนความสามารถในการช าระภาระผูกพัน (debt service coverage ratio) (4) อัตราหนี้สินรวมต่อส่วนของผู้ถือหุ้นรวม (debt to equity ratio) (5) อัตราส่วนสภาพคล่อง (current ratio) (6) อัตราส่วนตั๋วเงินจ่ายต่อหนี้
and total liabilities stood at THB 6,714.9mn. • Debt to Equity ratio2 equals 1.00 times as of 31 March 2020, decreased from 1.04 times as at end of 2019. Operating result 1Q/2020 Revenue Source of
www.interpharma.co.th 6. Approve to present to the Shareholders' Meeting to consider and approve the issuance of debentures in the amount not exceeding 300 million Baht. The total debt burden of the Company at any one
, 2017 Increase (Decrease) % Current assets 26,767.98 23,525.93 3,242.05 13.8 Non-current assets 71,328.60 70,698.90 629.70 0.9 Total Assets 98,096.58 94,224.83 3,871.75 4.1 3.1.1 Cash and cash equivalents
i ed ) Current Assets 202.85 362.95 -160.10 -44.11 Non-Current Assets 205.76 686.62 -480.86 -70.03 Total Assets 408.61 1049.57 -640.96 -61.07 Current Liabilities 300.40 405.82 -105.42 -25.98 Non
– 20 (MB) (MB) % Cash and cash equivalents 378.5 204.5 174.0 85.1 Other current financial assets 720.0 - 720.0 100.0 Trade Account Receivables 2,070.8 2,633.9 (563.1) (21.4) Contract assets 913.5 1,303.9